Tumorend, LLC Building 340, East Parker Drive Category: Pharmaceutical Manufacturers
|
More Contacts Of Tumorend, LLC
2252683052 (Contact)
Company representatives
Phone: 5043901700
Email: ten.htuoslleb@cnicla
Roger A Laine, CEO
About Tumorend, LLC
Biological Anti-Angiogenesis Tumor Therapeutics, Pharmaceuticals
Biological CM101 interacts with HP59 (See Wikipedia) on tumor capillary endothelium, induces complement activation and an acute inflammatory response in the tumor vasculature and surrounding tumor. Tumorend is conducting clinical trials and developing CM101 as an anti-solid tumor agent.
Products and Services
- Antitumor biological pharmaceuticals
- vaccines
Location Type
Headquarters
Revenue
$275,000 - $300,000
Employees
2 to 4
Years In Business
16
Brands
- CM101
Rating
Browse U.S. states for Pharmaceutical Manufacturers
